tiprankstipranks
XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB)
NASDAQ:XTLB
US Market
XTLB
XTL Biopharmaceuticals Sponsored ADR
RESEARCH TOOLSreports
Want to see XTLB full AI Analyst Report?

XTL Biopharmaceuticals Sponsored ADR (XTLB) Stock News & Sentiment

143 Followers
XTL Biopharmaceuticals Faces Added Nasdaq Delisting Risk Over Late 2025 Annual Report
Premium
Company Announcements
XTL Biopharmaceuticals Faces Added Nasdaq Delisting Risk Over Late 2025 Annual Report
2h ago
6K
XTLB
XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise
Premium
Company Announcements
XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise
7d ago
6K
XTLB
XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal
Premium
Company Announcements
XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal
15d ago
6K
XTLB
XTL Biopharmaceuticals Delays 20-F Amid Subsidiary Liquidation
Premium
Company Announcements
XTL Biopharmaceuticals Delays 20-F Amid Subsidiary Liquidation
22d ago
XTLB
3 Penny Stocks to Watch Now, 4/30/26
Premium
Market News
3 Penny Stocks to Watch Now, 4/30/26
22d ago
AKAN
RDAC
XTL Biopharmaceuticals to Acquire PsygaBio in All-Stock Deal to Expand Psychedelic Drug Pipeline
Premium
Company Announcements
XTL Biopharmaceuticals to Acquire PsygaBio in All-Stock Deal to Expand Psychedelic Drug Pipeline
23d ago
6K
XTLB
Upcoming Stock Splits This Week (March 23 to March 27) – Stay Invested
Premium
Market News
Upcoming Stock Splits This Week (March 23 to March 27) – Stay Invested
2M ago
AZI
JFB
More XTLB News >

XTLB News on the Web

XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise
TipRanks News
Neutral
XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal
TipRanks News
Bearish
XTL Biopharmaceuticals Delays 20-F Amid Subsidiary Liquidation
TipRanks News
Bearish
3 Penny Stocks to Watch Now, 4/30/26
TipRanks News
Bullish
XTL Biopharmaceuticals (XTLB) to Acquire Psyga Bio, Shares Surge 58.7%
GuruFocus News
Bullish
XTL Biopharmaceuticals to Acquire PsygaBio in All-Stock Deal to Expand Psychedelic Drug Pipeline
TipRanks News
Bearish
XTL Biopharmaceuticals to acquire Psyga Bio
TipRanks News
Bullish
XTL Biopharmaceuticals Makes Bold Psychedelic Bet With Psyga Bio Acquisition—Positioning for Clinical and Manufacturing Leadership
Market Chameleon
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
XTLB
Sector Average
Media Buzz
This Week1 articles
Weekly Average2 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is XTLB’s Media Buzz Sentiment?
1 articles about XTLB were published this week. In an average week, 2 articles are published.
    What is XTLB’s weekly average amount of articles?
    In an average week, 2 articles about XTLB are published.
      What is XTLB’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      GOSSGossamer Bio
      RLAYRelay Therapeutics
      ROIVRoivant Sciences
      ILAIsland Pharmaceuticals Ltd
      JUNSJupiter Neurosciences, Inc.
      Showing the stocks with the most bullish news sentiment over the past week